Carla Ferreira-Baptista
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Carla Ferreira-Baptista has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Bruno Colaço
Veterinary and Animal Research Centre (CECAV), University of Trás-os-Montes and Alto Douro (UTAD), 5000-801 Vila Real, Portugal
3 shared publications - Pedro Sousa Gomes
Bone Lab, Faculdade de Medicina Dentária, Universidade do Porto, 4200-393 Porto, Portugal
3 shared publications - Maria Helena Fernandes
Bone Lab, Faculdade de Medicina Dentária, Universidade do Porto, 4200-393 Porto, Portugal
2 shared publications - Rita Ferreira
University of Aveiro
2 shared publications - Alberto Carlos Botazzo Delbem
Universidade Estadual Paulista
1 shared publication - Alexandre Henrique dos Reis-Prado
Department of Restorative Dentistry, School of Dentistry, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil
1 shared publication
Latest Publications
- 8 September 2025
- Published by Springer Nature in European Archives of Paediatric Dentistry
- Vol. 27 (2) , 349-366
Effects of isotretinoin on bone dynamics in the craniomaxillofacial region: a systematic review of preclinical evidence
Purpose This systematic review provides a critical evaluation, synthesis of the existing literature on isotretinoin’s effects on craniomaxillofacial bone. Methods Following the PRISMA guidelines and registered in PROSPERO, the review was conducted in August 2024 across various databases. Eligible in vivo studies were analysed for their assessment of isotretinoin’s effects on craniomaxillofacial bone. Risk of bias was performed according to the Systematic Review Centre for Laboratory Animal Experimentation’s RoB tool for animal studies. Results Out of 3670 studies, eight were eligible. Four studies revealed increased hyalinised areas in specific dental root regions amongst isotretinoin-treated groups, alongside significant differences in osteoblast and osteoclast counts, capillary formation, and new bone growth, indicating isotretinoin’s impact on bone tissue. Two studies reported no significant disparities in trabecular bone structure but observed variations in collagen formation, root resorption, and bone resorption frequency. Studies on isotretinoin’s effects on bone repair reveal contrasting outcomes: higher doses (7.5 mg/kg/day) enhanced bone formation in calvaria defects, whilst lower doses (1 mg/kg/day) slowed bone healing in a rabbit rhinoplasty model, showing reduced healing rates compared to controls. Conclusions The reviewed studies indicate that isotretinoin has dose-dependent effects on bone remodelling. Higher doses enhance bone formation and alveolar repair but increase root resorption and alter bone morphology, whilst lower doses slow bone healing. Some studies report no significant changes in bone volume or displacement but note improved gingival healing. These findings emphasise the need for further research to guide clinical decisions on isotretinoin’s long-term impact on craniomaxillofacial bone health.
- 8 September 2025
- Published by Springer Nature in European Archives of Paediatric Dentistry
- Vol. 27 (2) , 349-366
Effects of isotretinoin on bone dynamics in the craniomaxillofacial region: a systematic review of preclinical evidence
Purpose This systematic review provides a critical evaluation, synthesis of the existing literature on isotretinoin’s effects on craniomaxillofacial bone. Methods Following the PRISMA guidelines and registered in PROSPERO, the review was conducted in August 2024 across various databases. Eligible in vivo studies were analysed for their assessment of isotretinoin’s effects on craniomaxillofacial bone. Risk of bias was performed according to the Systematic Review Centre for Laboratory Animal Experimentation’s RoB tool for animal studies. Results Out of 3670 studies, eight were eligible. Four studies revealed increased hyalinised areas in specific dental root regions amongst isotretinoin-treated groups, alongside significant differences in osteoblast and osteoclast counts, capillary formation, and new bone growth, indicating isotretinoin’s impact on bone tissue. Two studies reported no significant disparities in trabecular bone structure but observed variations in collagen formation, root resorption, and bone resorption frequency. Studies on isotretinoin’s effects on bone repair reveal contrasting outcomes: higher doses (7.5 mg/kg/day) enhanced bone formation in calvaria defects, whilst lower doses (1 mg/kg/day) slowed bone healing in a rabbit rhinoplasty model, showing reduced healing rates compared to controls. Conclusions The reviewed studies indicate that isotretinoin has dose-dependent effects on bone remodelling. Higher doses enhance bone formation and alveolar repair but increase root resorption and alter bone morphology, whilst lower doses slow bone healing. Some studies report no significant changes in bone volume or displacement but note improved gingival healing. These findings emphasise the need for further research to guide clinical decisions on isotretinoin’s long-term impact on craniomaxillofacial bone health.
- Open Access
Exploring the Potential of Non-Cellular Orthobiologic Products in Regenerative Therapies for Stifle Joint Diseases in Companion Animals
Stifle joint diseases present a significant challenge in companion animals that often lead to hind limb lameness, with osteoarthritis being a prevalent degenerative condition causing pain and reduced mobility. Regenerative medicine offers a promising avenue for improving treatment outcomes, with a range of emerging therapies showing potential to alleviate symptoms and promote joint health. Among these, hyaluronic acid and platelet-rich plasma have been widely used as intra-articular treatments to enhance joint lubrication, reduce inflammation, and provide symptomatic relief. Interleukin-1 receptor antagonist protein, autologous conditioned serum, and autologous protein solution represent the next generation of regenerative therapies, offering more disease-modifying effects by inhibiting key mediators of joint inflammation. More recently, the MSC-derived secretome has emerged as an innovative, cell-free approach that leverages the diverse bioactive factors secreted by MSCs to support tissue repair and modulate inflammation. This review highlights the evidence base behind these non-cellular orthobiologic treatments for stifle joint disease, aiming to inform veterinary practitioners and owners about available options and their efficacy in supporting conventional treatments.
Open AccessExploring the Potential of Non-Cellular Orthobiologic Products in Regenerative Therapies for Stifle Joint Diseases in Companion Animals
Stifle joint diseases present a significant challenge in companion animals that often lead to hind limb lameness, with osteoarthritis being a prevalent degenerative condition causing pain and reduced mobility. Regenerative medicine offers a promising avenue for improving treatment outcomes, with a range of emerging therapies showing potential to alleviate symptoms and promote joint health. Among these, hyaluronic acid and platelet-rich plasma have been widely used as intra-articular treatments to enhance joint lubrication, reduce inflammation, and provide symptomatic relief. Interleukin-1 receptor antagonist protein, autologous conditioned serum, and autologous protein solution represent the next generation of regenerative therapies, offering more disease-modifying effects by inhibiting key mediators of joint inflammation. More recently, the MSC-derived secretome has emerged as an innovative, cell-free approach that leverages the diverse bioactive factors secreted by MSCs to support tissue repair and modulate inflammation. This review highlights the evidence base behind these non-cellular orthobiologic treatments for stifle joint disease, aiming to inform veterinary practitioners and owners about available options and their efficacy in supporting conventional treatments.
- Open Access
- 24 November 2023
- Published by MDPI AG in Veterinary Sciences
- Vol. 10 (12) , 673
Influence of the Anatomical Site on Adipose Tissue-Derived Stromal Cells’ Biological Profile and Osteogenic Potential in Companion Animals
Adipose tissue-derived stromal cells (ADSCs) have generated considerable interest in the field of veterinary medicine, particularly for their potential in therapeutic strategies focused on bone regeneration. These cells possess unique biological characteristics, including their regenerative capacity and their ability to produce bioactive molecules. However, it is crucial to recognize that the characteristics of ADSCs can vary depending on the animal species and the site from which they are derived, such as the subcutaneous and visceral regions (SCAT and VAT, respectively). Thus, the present work aimed to comprehensively review the different traits of ADSCs isolated from diverse anatomical sites in companion animals, i.e., dogs, cats, and horses, in terms of immunophenotype, morphology, proliferation, and osteogenic differentiation potential. The findings indicate that the immunophenotype, proliferation, and osteogenic potential of ADSCs differ according to tissue origin and species. Generally, the proliferation rate is higher in VAT-derived ADSCs in dogs and horses, whereas in cats, the proliferation rate appears to be similar in both cells isolated from SCAT and VAT regions. In terms of osteogenic differentiation potential, VAT-derived ADSCs demonstrate the highest capability in cats, whereas SCAT-derived ADSCs exhibit superior potential in horses. Interestingly, in dogs, VAT-derived cells appear to have greater potential than those isolated from SCAT. Within the VAT, ADSCs derived from the falciform ligament and omentum show increased osteogenic potential, compared to cells isolated from other anatomical locations. Consequently, considering these disparities, optimizing isolation protocols becomes pivotal, tailoring them to the specific target species and therapeutic aims, and judiciously selecting the anatomical site for ADSC isolation. This approach holds promise to enhance the efficacy of ADSCs-based bone regenerative therapies.
- 24 November 2023
- Published by MDPI AG in Veterinary Sciences
- Vol. 10 (12) , 673
Open AccessInfluence of the Anatomical Site on Adipose Tissue-Derived Stromal Cells’ Biological Profile and Osteogenic Potential in Companion Animals
Adipose tissue-derived stromal cells (ADSCs) have generated considerable interest in the field of veterinary medicine, particularly for their potential in therapeutic strategies focused on bone regeneration. These cells possess unique biological characteristics, including their regenerative capacity and their ability to produce bioactive molecules. However, it is crucial to recognize that the characteristics of ADSCs can vary depending on the animal species and the site from which they are derived, such as the subcutaneous and visceral regions (SCAT and VAT, respectively). Thus, the present work aimed to comprehensively review the different traits of ADSCs isolated from diverse anatomical sites in companion animals, i.e., dogs, cats, and horses, in terms of immunophenotype, morphology, proliferation, and osteogenic differentiation potential. The findings indicate that the immunophenotype, proliferation, and osteogenic potential of ADSCs differ according to tissue origin and species. Generally, the proliferation rate is higher in VAT-derived ADSCs in dogs and horses, whereas in cats, the proliferation rate appears to be similar in both cells isolated from SCAT and VAT regions. In terms of osteogenic differentiation potential, VAT-derived ADSCs demonstrate the highest capability in cats, whereas SCAT-derived ADSCs exhibit superior potential in horses. Interestingly, in dogs, VAT-derived cells appear to have greater potential than those isolated from SCAT. Within the VAT, ADSCs derived from the falciform ligament and omentum show increased osteogenic potential, compared to cells isolated from other anatomical locations. Consequently, considering these disparities, optimizing isolation protocols becomes pivotal, tailoring them to the specific target species and therapeutic aims, and judiciously selecting the anatomical site for ADSC isolation. This approach holds promise to enhance the efficacy of ADSCs-based bone regenerative therapies.
- Open Access
- 15 December 2022
- Published by MDPI AG in Bioengineering
- Vol. 9 (12) , 810
The Osteogenic Potential of Falciform Ligament-Derived Stromal Cells—A Comparative Analysis between Two Osteogenic Induction Programs
Mesenchymal stromal cells (MSCs) have gained special relevance in bone tissue regenerative applications. MSCs have been isolated from different depots, with adipose tissue being acknowledged as one of the most convenient sources, given the wide availability, high cellular yield, and obtainability. Recently, the falciform ligament (FL) has been regarded as a potential depot for adipose tissue-derived stromal cells (FL-ADSCs) isolation. Nonetheless, the osteogenic capability of FL-ADSCs has not been previously characterized. Thus, the present study aimed the detailed characterization of FL-ADSCs’ functionality upon osteogenic induction through a classic (dexamethasone-based-DEX) or an innovative strategy with retinoic acid (RA) in a comparative approach with ADSCs from a control visceral region. Cultures were characterized for cell proliferation, metabolic activity, cellular morphology, fluorescent cytoskeletal and mitochondrial organization, and osteogenic activity–gene expression analysis and cytochemical staining. FL-derived populations expressed significantly higher levels of osteogenic genes and cytochemical markers, particularly with DEX induction, as compared to control ADSCs that were more responsive to RA. FL-ADSCs were identified as a potential source for bone regenerative applications, given the heightened osteogenic functionality. Furthermore, data highlighted the importance of the selection of the most adequate osteogenic-inducing program concerning the specificities of the basal cell population.
- 15 December 2022
- Published by MDPI AG in Bioengineering
- Vol. 9 (12) , 810
Open AccessThe Osteogenic Potential of Falciform Ligament-Derived Stromal Cells—A Comparative Analysis between Two Osteogenic Induction Programs
Mesenchymal stromal cells (MSCs) have gained special relevance in bone tissue regenerative applications. MSCs have been isolated from different depots, with adipose tissue being acknowledged as one of the most convenient sources, given the wide availability, high cellular yield, and obtainability. Recently, the falciform ligament (FL) has been regarded as a potential depot for adipose tissue-derived stromal cells (FL-ADSCs) isolation. Nonetheless, the osteogenic capability of FL-ADSCs has not been previously characterized. Thus, the present study aimed the detailed characterization of FL-ADSCs’ functionality upon osteogenic induction through a classic (dexamethasone-based-DEX) or an innovative strategy with retinoic acid (RA) in a comparative approach with ADSCs from a control visceral region. Cultures were characterized for cell proliferation, metabolic activity, cellular morphology, fluorescent cytoskeletal and mitochondrial organization, and osteogenic activity–gene expression analysis and cytochemical staining. FL-derived populations expressed significantly higher levels of osteogenic genes and cytochemical markers, particularly with DEX induction, as compared to control ADSCs that were more responsive to RA. FL-ADSCs were identified as a potential source for bone regenerative applications, given the heightened osteogenic functionality. Furthermore, data highlighted the importance of the selection of the most adequate osteogenic-inducing program concerning the specificities of the basal cell population.
- Open Access
- 1 January 2016
- Published by Frontiers Media SA in Frontiers in Marine Science
- Vol. 3
Essential oil of two plant species from Peniche coast (Crithmum maritimum l. and Juniperus phoenicea var. turbinata (Guss.) parl.): Assessment of antimicrobial and antioxidant activities
The organisms that make up the terrestrial and marine interface provide a wide range of resources and functional compounds, which work as a source for substances with antimicrobial, antioxidant, antifungal and even antitumor activity. Coastal sand dunes are subjected to severe environmental stresses and disturbance, caused by salinity, drought, nutrient limitation, substrate instability, sand burial, wind abrasion, erosion of the coastline and storms. Sand-dune plant species, due to their understudied and unexplored stress adaptation mechanisms and strategies present an opportunity for the discovery of new bioactive molecules. Plants have the ability to produce compounds characteristic of a taxonomic group (i.e. family, genus and species) through metabolic pathways originating the secondary metabolites. The biosynthesis of these metabolites is restricted to specific stages of the development and specialized cells of the plant, and can be induced by the stress caused by nutrient deficiency or by the attack by organisms. Secondary metabolites are involved in functions such as providing characteristic odors, pungencies and colors; plant-plant relations and plant-animal interaction and providing culinary, medicinal or poisonous properties to plants. Although the functions of many secondary metabolites are already well-known, for a great part of these the value to the plant is still unknown. Essential oils are secondary metabolites and they are produced in a wide range of plant species, called aromatic plants. These are complex mixtures, with a specific color, smell and physico-chemical composition. The aim of this study was to evaluate the ability of essential oils obtained from two native plants of the Peniche coast as antibacterial and antioxidant agents. The plants selected and studied for this purpose were Crithmum maritimum and Juniperus phoenicea var. turbinata. C. maritimum (Apiaceae) is a facultative halophile found all over the European coast, whose leaves are rich in bioactive substances used as insecticides, flavorings and antimicrobial agents. Juniperus phoenicea var. turbinata (Cupressaceae) is a coastal plant spread throughout the Mediterranean whose leaves and galbulus are used in bronco-pulmonary disease treatment. Essential oil extraction was made by hydrodestilation with a Clevenger apparatus and once extracted the oil was evaluated for its antibacterial ability using a disk diffusion method considering commercial antibiotic disks as positive controls and dimethyl sulfoxide (DMSO) as a negative control. The strains used were: two gram-positive bacteria, Bacillus sp. (ATCC6633) and Staphylococcus aureus (ATCC25923); and three gram-negative bacteria, Pseudomonas sp. (ATCC27853), E. coli (ATCC5922) and Salmonella sp. (ATCC13076)). Antioxidant activity of the oils and a commercial standard (butylated hydroxytoluene – BHT) was evaluated using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical-scavenging method and thiobarbituric acid reactive substances assay (TBARS). Both species present high extraction yield of essential oil, with J. phoenicea var. turbinata slightly higher. The oils showed significant antimicrobial and antioxidant activities, with C. maritimum more active than J. phoenicea var. turbinata, revealing the presence of bioactive compounds in both essential oils, making them potential resources for biotechnological innovation. Further analysis are needed in order to determine the exact composition of both essential oils and compare the results obtained with the essential oils obtained from the same species grown in other environments.
- 1 January 2016
- Published by Frontiers Media SA in Frontiers in Marine Science
- Vol. 3
Open AccessEssential oil of two plant species from Peniche coast (Crithmum maritimum l. and Juniperus phoenicea var. turbinata (Guss.) parl.): Assessment of antimicrobial and antioxidant activities
The organisms that make up the terrestrial and marine interface provide a wide range of resources and functional compounds, which work as a source for substances with antimicrobial, antioxidant, antifungal and even antitumor activity. Coastal sand dunes are subjected to severe environmental stresses and disturbance, caused by salinity, drought, nutrient limitation, substrate instability, sand burial, wind abrasion, erosion of the coastline and storms. Sand-dune plant species, due to their understudied and unexplored stress adaptation mechanisms and strategies present an opportunity for the discovery of new bioactive molecules. Plants have the ability to produce compounds characteristic of a taxonomic group (i.e. family, genus and species) through metabolic pathways originating the secondary metabolites. The biosynthesis of these metabolites is restricted to specific stages of the development and specialized cells of the plant, and can be induced by the stress caused by nutrient deficiency or by the attack by organisms. Secondary metabolites are involved in functions such as providing characteristic odors, pungencies and colors; plant-plant relations and plant-animal interaction and providing culinary, medicinal or poisonous properties to plants. Although the functions of many secondary metabolites are already well-known, for a great part of these the value to the plant is still unknown. Essential oils are secondary metabolites and they are produced in a wide range of plant species, called aromatic plants. These are complex mixtures, with a specific color, smell and physico-chemical composition. The aim of this study was to evaluate the ability of essential oils obtained from two native plants of the Peniche coast as antibacterial and antioxidant agents. The plants selected and studied for this purpose were Crithmum maritimum and Juniperus phoenicea var. turbinata. C. maritimum (Apiaceae) is a facultative halophile found all over the European coast, whose leaves are rich in bioactive substances used as insecticides, flavorings and antimicrobial agents. Juniperus phoenicea var. turbinata (Cupressaceae) is a coastal plant spread throughout the Mediterranean whose leaves and galbulus are used in bronco-pulmonary disease treatment. Essential oil extraction was made by hydrodestilation with a Clevenger apparatus and once extracted the oil was evaluated for its antibacterial ability using a disk diffusion method considering commercial antibiotic disks as positive controls and dimethyl sulfoxide (DMSO) as a negative control. The strains used were: two gram-positive bacteria, Bacillus sp. (ATCC6633) and Staphylococcus aureus (ATCC25923); and three gram-negative bacteria, Pseudomonas sp. (ATCC27853), E. coli (ATCC5922) and Salmonella sp. (ATCC13076)). Antioxidant activity of the oils and a commercial standard (butylated hydroxytoluene – BHT) was evaluated using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical-scavenging method and thiobarbituric acid reactive substances assay (TBARS). Both species present high extraction yield of essential oil, with J. phoenicea var. turbinata slightly higher. The oils showed significant antimicrobial and antioxidant activities, with C. maritimum more active than J. phoenicea var. turbinata, revealing the presence of bioactive compounds in both essential oils, making them potential resources for biotechnological innovation. Further analysis are needed in order to determine the exact composition of both essential oils and compare the results obtained with the essential oils obtained from the same species grown in other environments.